These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7468704)

  • 21. The effect of prostaglandin F2alpha on the placental progesterone level in midtrimester abortion.
    Aleem FA; Schulman H; Saldana LR; Hung HC
    Am J Obstet Gynecol; 1975 Sep; 123(2):202-5. PubMed ID: 1163583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation.
    Kafrissen ME; Schulz KF; Grimes DA; Cates W
    JAMA; 1984 Feb; 251(7):916-9. PubMed ID: 6582285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of midtrimester pregnancy termination by laminaria and evacuation in patients with previous cesarean section.
    Schneider D; Bukovsky I; Caspi E
    Am J Obstet Gynecol; 1994 Aug; 171(2):554-7. PubMed ID: 8059841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-amniotic prostaglandin F2alpha and urea for midtrimester abortion.
    Wellman L; Jacobson A
    Fertil Steril; 1976 Dec; 27(12):1374-9. PubMed ID: 1001522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intramuscular administration of 15(S) 15 methyl prostaglandin E2 methyl ester for induction of abortion: a comparison of two dose schedules.
    Brenner WE; Dingfelder JR; Staurovsky LG; Kumarasamy T; Grimes DA
    Fertil Steril; 1975 Apr; 26(4):369-79. PubMed ID: 1116632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of a nonsurgical method to terminate very early pregnancy in comparison to vacuum aspiration.
    Rosén AS; Nystedt L; Bygdeman M; Lundström V
    Contraception; 1979 Feb; 19(2):107-17. PubMed ID: 428228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Termination of midtrimester missed abortion by extraovular instillation of normal saline.
    Abramovici H; Rofé A; Atad J; Lewin A
    Br J Obstet Gynaecol; 1981 Sep; 88(9):931-3. PubMed ID: 7272266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrafetal prostaglandin F2 alpha administration for midtrimester pregnancy termination: a case report.
    Christodoulou CN; Kotoulas IG; Agapitos EB; Germanos AK
    Am J Obstet Gynecol; 1990 May; 162(5):1245-6. PubMed ID: 2187355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vacuum aspiration at therapeutic abortion: blood loss at operation in multigravid women.
    Sandström B; Segerbrand E; Solheim F
    Gynecol Obstet Invest; 1978; 9(6):292-8. PubMed ID: 754990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of midtrimester abortion techniques on patients and staff.
    Kaltreider NB; Goldsmith S; Margolis AJ
    Am J Obstet Gynecol; 1979 Sep; 135(2):235-8. PubMed ID: 474678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in therapeutic abortion in San Francisco.
    Goldstein P; Stewart G
    Am J Public Health; 1972 May; 62(5):695-9. PubMed ID: 5024298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of induced abortion.
    Hepburn S
    Fam Plann Inf Serv; 1981 Apr; 1(6):21-8. PubMed ID: 12263451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal amniotic fluid embolism during legally induced abortion, United States, 1972 to 1978.
    Guidotti RJ; Grimes DA; Cates W
    Am J Obstet Gynecol; 1981 Oct; 141(3):257-61. PubMed ID: 7282806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-fetoprotein concentration in maternal serum and abortion via VA and PGF2alpha.
    Sande HA; Fagerhol M
    Int J Gynaecol Obstet; 1978; 15(5):419-22. PubMed ID: 80339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins and abortion. II. Single extra-amniotic administration of 0.92 mg. of 15-methyl prostaglandin F2alpha in Hyskon for termination of pregnancies in weeks 10 to 20 of gestation: an international multicenter study. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):597-600. PubMed ID: 920760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.